Pahl Nanobiotherapeutics Private Limited - Company Profile

It is a research & development private limited company based in Secunderabad, Telangana, India, established in 2013.
2013 Secunderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Pahl Nanobiotherapeutics Private Limited

Pahl Nanobiotherapeutics Private Limited, a struck off private limited company, was established on 25 July 2013 in Secunderabad, Telangana, India. Engaging in science research within the research & development sector, it holds CIN: U73100TG2013PTC089126. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Praveer Kumar Gupta (Director), Yamini Asthana (Director). It is based at Plot No.107,Teacher'S Colony, Trimulgherry,, Secunderabad, Telangana, 500015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100TG2013PTC089126

  • Registration Number

    089126

  • Incorporation Date

    25 July 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 7 Months
Company report

Pahl Nanobiotherapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pahl Nanobiotherapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pahl Nanobiotherapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Praveer Kumar Gupta Director 25 Jul 2013 Current
Yamini Asthana Director 25 Jul 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pahl Nanobiotherapeutics.

Enhance accessibility to Pahl Nanobiotherapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pahl Nanobiotherapeutics revenue growth over time
Pahl Nanobiotherapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pahl Nanobiotherapeutics?

Unlock access to Pahl Nanobiotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pahl Nanobiotherapeutics?

Unlock and access historical data on people associated with Pahl Nanobiotherapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pahl Nanobiotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pahl Nanobiotherapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pahl Nanobiotherapeutics
Recent Activity within the Organization
  • Director Appointment

    The activity Praveer Kumar Gupta was appointed as a Director was appointed as a Director on 25 Jul 2013 & has been associated with this company since 12 years 7 months . was completed.

  • Director Appointment

    Yamini Asthana was appointed as a Director was appointed as a Director on 25 Jul 2013 & has been associated with this company since 12 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Pahl Nanobiotherapeutics Private Limited was registered on 25 Jul 2013 with Roc Hyderabad & aged 12 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pahl Nanobiotherapeutics Private Limited?

The CIN of Pahl Nanobiotherapeutics Private Limited is U73100TG2013PTC089126.

Where is Pahl Nanobiotherapeutics Private Limited headquartered?

Pahl Nanobiotherapeutics Private Limited is headquartered at Plot No.107,Teacher'S Colony, Trimulgherry,, Secunderabad, Telangana, 500015.

When was Pahl Nanobiotherapeutics Private Limited incorporated?

Pahl Nanobiotherapeutics Private Limited was incorporated on 25 July 2013.

Who are the current directors of Pahl Nanobiotherapeutics Private Limited?

The current directors of Pahl Nanobiotherapeutics Private Limited are

What is the primary industry of Pahl Nanobiotherapeutics Private Limited?

The primary industry of Pahl Nanobiotherapeutics Private Limited is Research & Development.

Is Pahl Nanobiotherapeutics Private Limited a listed company?

Pahl Nanobiotherapeutics Private Limited is unlisted.

What is the capital structure of Pahl Nanobiotherapeutics Private Limited?

The authorized capital of Pahl Nanobiotherapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available